OCUL
OCUL
US67576A1007
Ocular Therapeutix, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.66B EUR
2.16B EUR
1.85B EUR
2.62B EUR
Enterprise Value
1.13B EUR
1.64B EUR
1.27B EUR
1.96B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-5.19x
--
--
--
Price to Sales
31.81x
41.43x
35.63x
63.54x
Price to Book
3.18x
4.15x
3.19x
4.01x
EV/Revenue
21.71x
31.45x
24.34x
47.54x
EV/EBITDA
-3.66x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-9.62%
-11.83%
-13%
-6.5%
ende